Cambridge Needs Assessment
The first step of this process is to conduct a comprehensive Needs Assessment. The primary purpose of the Needs Assessment is to gain an in-depth understanding of the community's most pressing needs and service gaps.
Cambridge Foundry Advisory Committee Deadline Extended to June 30, 2015
This group will advise and provide regular updates to the City Manager and the Executive Director of the Cambridge Redevelopment Authority on proposed uses within the Foundry building, which will be redeveloped and operated consistent with the vision and objectives that resulted from an extensive community planning process..
COVID-19 Vaccine Frequently Asked Questions
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
COVID-19 Vaccine Frequently Asked Questions (as of December 23, 2020)
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.